0001235802-22-000134.txt : 20221208
0001235802-22-000134.hdr.sgml : 20221208
20221208165507
ACCESSION NUMBER: 0001235802-22-000134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221206
FILED AS OF DATE: 20221208
DATE AS OF CHANGE: 20221208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Giuffre Randall Michael
CENTRAL INDEX KEY: 0001759822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 221453035
MAIL ADDRESS:
STREET 1: 2 CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY
STREET 2: SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-12-06
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001759822
Giuffre Randall Michael
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS
MN
55305
1
0
0
0
Voting Common Shares, no par value per share
2022-12-06
4
P
0
2300
1.35
A
180572
D
Voting Common Shares, no par value per share
2022-12-07
4
P
0
22574
1.4
A
203146
D
Voting Common Shares, no par value per share
25573
I
See footnote
Voting Common Shares, no par value per share
21070
I
By Spouse
Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 107,811 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.40, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.
These voting common shares are held by 424822 Albert Ltd, of which Michael Giuffre has sole voting and dispositive power.
/s/ Amy Culbert, attorney-in-fact
2022-12-08